Citius Pharmaceuticals, Inc. (CTXR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Citius Pharmaceuticals, Inc. on June 3, 2025, reporting events occurring on June 2, 2025. The Company is incorporated in Nevada and trades on The Nasdaq Capital Market under the symbol CTXR.
Key Financial Metrics and Obligations
The filing discloses the creation of a new direct financial obligation. The Company issued an unsecured promissory note with the following terms:
- Principal Amount: $1,000,000
- Lender: PAGODA RESOURCES, INC.
- Interest Rate: 15.00% per year, compounded monthly
- Maturity Date: December 2, 2025
- Security: Unsecured, but personally guaranteed by Leonard Mazur, Chairman and CEO
- Prepayment: Allowed in whole or in part at any time without penalty
The filing does not provide current revenue, profit, cash flow, or existing debt levels. The filing text does not provide a clear value for the Company's current liquidity position outside of this new obligation.
Material Changes
The primary material change is the incurrence of a $1 million debt obligation. This represents a new liability on the balance sheet effective June 2, 2025. The note is not convertible into equity.
Outlook, Risks, and Contingencies
Risks and Contingencies:
- Default Risk: The note contains customary events of default. If a default occurs and is not cured, the entire outstanding obligation may be accelerated.
- Personal Guarantee: Repayment is personally guaranteed by the Company's Chairman and CEO, Leonard Mazur.
- Interest Cost: The 15% annual interest rate, compounded monthly, represents a significant cost of capital.
Management Commentary: The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations beyond the terms of the note.
Key Facts for Investor Verification
- Verify the Company's current cash balance to assess its ability to service the 15% interest and repay the $1 million principal by December 2025.
- Review the full text of the Unsecured Promissory Note (Exhibit 10.1) for specific definitions of "events of default."
- Confirm if this borrowing is part of a broader financing strategy or an emergency liquidity measure.
- Check for any subsequent filings regarding the use of proceeds from this note.